/
Vol 82 No 203Monday October 23 2017Notices SUPPLEMENTARYINFORM Vol 82 No 203Monday October 23 2017Notices SUPPLEMENTARYINFORM

Vol 82 No 203Monday October 23 2017Notices SUPPLEMENTARYINFORM - PDF document

joyce
joyce . @joyce
Follow
356 views
Uploaded On 2022-09-07

Vol 82 No 203Monday October 23 2017Notices SUPPLEMENTARYINFORM - PPT Presentation

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No FDA1502017150P1503581 Determination That ELAVIL Amitriptyline Hydrochloride Oral AGENCY Food and Drug Admi ID: 952813

drug 150 food administration 150 drug administration food 161 314 2017 vol verdate hhs action notice 2017jkt sep20 oct

Share:

Link:

Embed:


Presentation Transcript

/Vol. 82, No. 203/Monday, October 23, 2017/Notices SUPPLEMENTARYINFORMATIONFurthermore, as specified in §60.30 (21 §60.30, including but not limited to: filed in accordance with §10.20, must DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2017–P–3581] Determination That ELAVIL (Amitriptyline Hydrochloride) Oral AGENCY: Food and Drug Administration, HHS. ACTION: Notice. FORFURTHERINFORMATIONCONTACTSUPPLEMENTARYINFORMATIONᄀVerDate Sep20:08 Oct 20, 2017Jkt 244001PO 00000Frm

00062Fmt 4703Sfmt 4703E:\FR\FM\23OCN1.SGM23OCN1 /Vol. 82, No. 203/Monday, October 23, 2017/Notices listed drug (§314.161 (21 CFR 314.161)). §314.161 that ELAVIL (amitriptyline DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2007–D–0369] Product-Specific Guidance for Methylphenidate Hydrochloride; New AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. ᄀVerDate Sep20:08 Oct 20, 2017Jkt 244001PO 00000Frm 00063Fmt 4703Sfmt 4703E:\FR\FM\23OCN1.SGM23OCN